Fumaric Acid

Fumaric Acid

SCHEMBL1794341

Cc1cc(-c2ccccc2)nnc1N1CC2CN(C)CC2C1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 3/20 0.51
HTR3A P46098 1/20 0.51
CHRNB4 P30926 1/20 0.51
CHRNA3 P32297 1/20 0.51
CHRNB2 P17787 1/20 0.44
CHRNA4 P43681 1/20 0.44
HCRTR1 O43613 5/20 0.39
HCRTR2 O43614 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL1794342 1.00 CHRNA7 (0.51) CHRNA7HTR3ACHRNB4CHRNA3CHRNB2
SCHEMBL926885 0.91 CHRNA7 (0.60) CHRNA7HTR3ACHRNB4CHRNA3CHRNB2
Fumaric Acid SCHEMBL15663041 0.80 CHRNA7 (0.81) CHRNA7HTR3ACHRNB4CHRNA3
Fumaric Acid SCHEMBL15663039 0.80 CHRNA7 (0.81) CHRNA7HTR3ACHRNB4CHRNA3
SCHEMBL928225 0.77 CHRNA7 (0.59) CHRNA7HTR3ACHRNB4CHRNA3CHRNB2
Fumaric Acid SCHEMBL928618 0.76 CHRNA7 (0.46) CHRNA7HTR3ACHRNB4CHRNA3CHRNB2
Fumaric Acid SCHEMBL928619 0.76 CHRNA7 (0.46) CHRNA7HTR3ACHRNB4CHRNA3CHRNB2
SCHEMBL1752927 0.73 HRH4 (0.51) HTR3A
SCHEMBL1752966 0.72 NEK2 (0.55)
SCHEMBL1752990 0.70 KMT2A (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2316836-A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors Abbott Laboratories (US) 2011-05-04 EP disclosed